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INTRODUCTION
Spontaneous bacterial peritonitis (SBP) is one of the
most common and life threatening complications of
cirrhosis which is characterized by the infection of
ascitic fluid in the absence of a concurrent intra-
abdominal source of infection (e.g. intra-abdominal
abscesses, intestinal perforation, cholecystitis or acute
pancreatitis).1 It can occur in 10-30% of cirrhotic patients
with ascites,2,3 having an in-hospital mortality rate of
around 30 to 50%.4 The risk of SBP recurrence is
around 70% per year.3 There is around 10% probability
of developing SBP in patients with end stage liver
disease and ascites over a period of one year.5
Altered host immune system and translocation of the
bacteria from the gut to the extra intestinal sites are
thought to be the basis for SBP.6 Long-term prophylaxis
with antibiotics like quinolones (Norfloxacin, 400 mg per
day orally) has reduced the recurrence rate.1 However,
emergence of quinolone resistant organisms has
lowered its use.7
Internationally published data shows that increased
serum bilirubin levels,8 derangement in serum
creatinine, presence of hyponatremia,9 and the use
of proton pump inhibitors (PPI)10 are the risk factors
associated with SBP. However, there is insufficient
regional and no local data on factors responsible for the
recurrence of SBP.
Therefore, the aim of this study was to determine the
factors predicting the recurrence of SBP in cirrhotic
patients with ascites.
METHODOLOGY
Cirrhotic patients admitted with the diagnosis of SBP at
The Aga Khan University Hospital (AKUH), Karachi,
from November 2008 to November 2009 were studied.
The term SBP refers to the presence of more than 250
neutrophils in ascitic fluid in the setting of cirrhosis, and
in the absence of bowel or peritoneal perforation.11
Any episode of SBP after resolution of the first index
case of SBP within one year was considered as
recurrence.4,12
The data of adult patients, more than 15 years of age,
admitted with the diagnosis of SBP during the study
period, was included. Patients in whom the improve-
ment of SBP was not documented (repeat ascitic tap 48
hours after the treatment was started) at the time of
discharge or those who were lost to follow-up during the
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study period were excluded. Similarly, patients with
chronic liver disease who were admitted with ascites
secondary to tuberculosis or malignancy were also
excluded.
Demographic data of patients was obtained from AKUH
during the study period through a pre-designed
questionnaire. The data included age, gender, etiology
of cirrhosis; co-morbids like diabetes, chronic kidney
disease (CKD) were noted. History of presenting
complains like fever, abdominal pain, constipation,
diarrhea, nausea, vomiting, history of gastrointestinal
bleed or PSE was also recorded.
Laboratory parameters included in the questionnaire
were total bilirubin, serum albumin, prothrombin time,
platelet count, serum creatinine, random blood sugar
and serum sodium. Presence of hepatitis B surface
antigen (HBsAg) and hepatitis C virus (HCV) antibodies
by micro enzyme immunoassay (MEIA), history of alcohol
intake, serum sodium and serum alpha fetoprotein were
also documented.
Ascitic fluid analysis at the time of admission as well as
repeat analysis done after 48 hours was also noted with
culture and sensitivities report of both.
In drug history, patients who were on PPIs, diuretics and
prophylactic antibiotics were also noted. Child turcotte
pugh (CTP) score and model for end stage liver disease
(MELD) score at the time of admission was calculated
and documented in the questionnaire. Length of hospital
stay and mortality were also parameters included in the
questionnaire.
Mortality was defined as patients who died due to
complications of SBP during that index admission.
A descriptive analysis was done for demographic and
clinical features and results are presented as mean ±
standard deviation for quantitative variables and number
(percentage) for qualitative variables. Differences in
proportions for recurrence of SBP in cirrhotic patients
with ascites were assessed by using the chi-square test
or Fisher’s exact test where appropriate. For contrasts
of continuous variables, independent sample t-test was
used to assess the difference of means. 
All significant factors on univariate analysis were
considered for inclusion in the multivariable logistic
model. All analyses were conducted by using the
Statistical Package for Social Sciences (SPSS version
16.0). All p-values were two-sided and considered as
statistically significant if < 0.05.
RESULTS
Three hundred and fifty patients were recruited during
one year out of which 41 were excluded due to no
documentation of SBP improvement at the time they
were discharged. Seventy-one were excluded because
they were lost to follow-up. Two hundred and thirty eight
cirrhotic patients were enrolled in the study out of whom
157 (66%) had single episode of SBP, while 81 (34%)
had recurrent episodes.
One hundred and thirty seven (57.6%) of the cirrhotic
patients admitted were males, while the female patients
numbered up to 101 (42.4%). The mean age was
50.47±12 years with the majority of population being
< 55 years i.e. 160 (67.2%).
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Table I: Demographic, clinical, ultrasonological and endoscopic
characteristics among all the study patients (n=238).
Characteristics Single Recurrent p-value
admission admission
n = 157 (66%) n = 81 (34%)
Age (years) 51 ± 13.31 50 ± 8.88 0.30
Age
< 55 years 100 (63.7%) 60 (74.1%) 0.10
> 55 years 57 (36.3%) 21 (25.9%)
Gender
Male 98 (62.4%) 39 (48.1%) 0.03
Female 59 (37.6%) 42 (51.9%)
Fever 80 (51%) 51 (63%) 0.08
Abdominal pain 85 (54.1%) 54 (66.7%) 0.06
CRF 29 (18.5%) 9 (11.1%) 0.14
PSE 72 (45.9%) 25 (30.9%) 0.03
Prothrombin time 
< 12 sec 13 (8.3%) 2 (2.5%) 0.08
> 12 sec (abnormal) 144 (91.7%) 79 (97.5%)
Bilirubin count
< 1.0 mg 20 (12.7%) 2 (2.5%) 0.01
> 1.0 mg (abnormal) 137 (87.3%) 79 (97.5%)
Serum creatinine
< 1.2 mg 74 (47.1%) 50 (61.7%) 0.03
> 1.2 mg (abnormal) 83 (52.9%) 31 (38.3%)
MELD score 
< 15 34 (21.7%) 21 (25.9%) 0.46
> 15 (abnormal) 123 (78.3%) 60 (74.1%)
Child Class
B 50 (31.8%) 17 (21%) 0.08
C 107 (68.2%) 64 (79%)
PPI used 75 (47.8%) 38 (46.9%) 0.9
Diuretic used 85 (54.1%) 54 (66.7%) 0.06
Prophylactic antibiotics 38 (24.2%) 20 (24.7%) 0.93
Large volume paracentesis 52 (33.1%) 33 (40.7%) 0.24
Esophageal varices 22 (14%) 19 (23.5%) 0.07
HCV CLD 87 (55.4%) 58 (71.6%) 0.01
HBV CLD 39 (24.8%) 9 (11.1%) 0.01
HBV+HDV CLD 15 (9.6%) 4 (4.9%) 0.21
ALD 7 (4.5%) 8 (9.9%) 0.10
DM 41 (26.1%) 31 (38.3%) 0.05
UTI 19 (12.1%) 16 (19.8%) 0.11
Non B non C CLD 30 (19.1%) 11 (13.6%) 0.28
Hepatocellular carcinoma 38 (24.2%) 11 (13.6%) 0.05
Mortality 31 (19.7%) 3 (3.7%) 0.001
Length of hospital stay 6.55 ± 5.11 5.07 ± 2.51 0.003
< 5 days 87 (55.4%) 56 (69.1%) 0.04
> 5 days 70 (44.6%) 25 (30.9%)
CI = Confidence Interval;   CRF = Chronic Renal Failure;   PSE = Porto-systemic Encephalopathy;
GI = Gastro-Intestinal;   MELD = Mean End Stage Liver Disease;   PPI = Proton Pump Inhibitor;
HCV CLD = Hepatitis C Virus Chronic Liver Disease;   HBV CLD = Hepatitis B Virus Chronic
Liver Disease;   HDV CLD = Hepatitis D Virus Chronic Liver Disease;   ALD = Alcoholic Liver
Disease;   DM = Diabetes  Mellitus;   UTI = Urinary Tract Infection.
The most common presenting complains were
abdominal pain 139(58.4%) and fever (n=131, 55%).
PSE was significantly seen in 97 (40.3%) patients. The
most common cause of cirrhosis was found to be HCV
related liver disease in 145 (60.9%) patients. While HBV
(20.2%), hepatitis D (HDV) (8%), non B non C CLD
(17.2%) and alcoholic liver disease (ALD) (6.3%) were
the causes in rest of the patients (Table I). Seventy-two
(30.3%) patients were found to have Diabetes as a co-
morbid condition, 35 (14.7%) had concurrent UTI.
Radiological diagnosis of HCC was present in 49
(20.6%) of the patients. Use of medicine (PPI and
diuretics) was found to be 113 (47.5%) and 139 (58.4%)
respectively. Fifty eight (24.4%) patients were on
prophylactic antibiotic therapy. The mean duration of
hospital stay amongst patients was found out to be
6 ± 5 days. Most of the patient admissions lasted less
than 5 days (n=143, 60.1%). The total mortality amongst
patients was 34 (14.3%).
Univariate analysis revealed that age above 55 years,
history of fever, abdominal pain, CRF, PSE, increased
prothrombin time or serum bilirubin, worsening serum
creatinine, advanced child class, used of diuretic and
presence of esophageal varices or HCC were found to
be statistically significant (Table II).
Using stepwise logistic regression age > 55 years
(OR=0.45; 95%CI=0.23-0.88), bilirubin count > 1.0 mg/dl
[(OR 7.03; 95%CI=1.55-32), protective factor of HBV
(OR 0.31; 95%CI=0.13-0.70)] and presence of UTI
[(OR=2.24; 95%CI=0.99-5.09) were found to be
independently significant factors in patients having
recurrent SBP (Table III).
DISCUSSION
In this study, it was aimed to identify factors that predict
the recurrence of SBP in patients with cirrhosis. A
Spanish study by Titó et al. found serum bilirubin > 4 mg
per dl, prothrombin activity < 45% and protein
concentration in ascitic fluid < 1 gm per dl to be
significantly (p < 0.05) associated with a high risk or re-
currence of SBP on univariate analysis, but on
multivariate analysis, only ascitic fluid protein
concentration (p = 0.005) and prothrombin activity (p =
0.009) were found to be independent predictors of re-
currence of SBP.12 Both of which were not significant in
this cohort but the significance of bilirubin as a predictor
for recurrence was confirmed. Another study showed
that serum creatinine and bilirubin are important
predictors in determining renal failure, advanced liver
disease and mortality.13
Diabetes mellitus as co-morbid was significant in
patients having recurrence of SBP on univariate
analysis, but not on multivariate analysis. The possible
mechanism can be altered immunity and deficiencies in
complement system with depressed functions of
neutrophils and macrophages in patients with cirrhosis.
It has been proven that cirrhotic patients with a lower
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Table II: Univariate analysis for factors predicting recurrent spontaneous
bacterial peritonitis.
Characteristic Odd ratio (95% CI) p-value
Age
< 55 years 1.0 0.10
> 55 years 0.61 (0.33 - 1.11)
Gender
Female 1.0
Male 0.55 (0.32 - 0.96) 0.03
Fever 1.63 (0.94-2.83) 0.07
Abdominal pain 1.69 (0.96-2.96) 0.06
CRF 0.55 (0.24-1.23) 0.14
PSE 0.52 (0.29-0.92) 0.03
Prothrombin time 
< 12 sec 1.0 0.10
> 12 sec (abnormal) 3.56 (0.78 - 16.20)
Bilirubin count
< 1.0 mg/dl 1.0 0.02
> 1.0 mg/dl (abnormal) 5.76 (1.31 - 25.32)
Serum creatinine
< 1.2 mg/dl 1.0 0.03
> 1.2 mg/dl (abnormal) 0.55 (0.32 - 0.95)
Child class
B 1.0 0.08
C 1.75 (0.93 - 3.30)
Diuretic  used 1.69 (0.96-2.96) 0.06
Esophageal varices 1.88 (0.94-3.72) 0.07
HCV CLD 2.02 (1.14-3.61) 0.01
HBV CLD 0.37 (0.17-0.82) 0.01
ALD 2.34 (0.82-6.72) 0.10
DM 1.75 (0.99-3.10) 0.05
UTI 1.78 (0.86-3.70) 0.11
Hepatocellular carcinoma 0.49 (0.23-1.02) 0.05
Mortality 0.15  (0.04-0.52) 0.003
Length of hospital stay
< 5 days 1.0 0.02
> 5 days 0.90 (0.83 - 0.98)
CI = Confidence Interval;  CRF = Chronic Renal Failure;  PSE = Porto-systemic
Encephalopathy;   HCV CLD = Hepatitis C Virus Chronic Liver Disease;   HBV CLD = Hepatitis
B Virus Chronic Liver Disease;   ALD = Alcoholic Liver Disease;   DM = Diabetes  Mellitus;
UTI = Urinary Tract Infection.
Table III: Multivariate analysis for factors predicting recurrent
spontaneous bacterial peritonitis.
Characteristics Odd ratio (95% CI) p-value
Age
< 55 years 1.0 0.02
> 55 years 0.45 (0.23 - 0.88)
Bilirubin count
< 1.0 mg/dl 1.0 0.01
> 1.0 mg/dl (abnormal) 7.03 (1.55 - 32)
HBV CLD
No 1.0 0.005
Yes 0.31 (0.13 - 0.70)
UTI
No 1.0 0.05
Yes 2.24 (0.99 - 5.09)
Mortality 0.12 (0.03-0.44) 0.001
CI = Confidence Interval;   HBV CLD = Hepatitis B Virus Chronic Liver Disease;
UTI = Urinary Tract Infection.
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level of serum C3 and C4 are more prone to develop
bacterial translocation.15,16 A recent study also found
association of proton pump inhibitor therapy with SBP,17
but its use was not statistically significant in the present
study population.
Patients with either single or recurrent episodes of SBP
have no significant difference between their CTP or
MELD scores. Although Hepatitis B related cirrhosis
was found out to be a protective factor for recurrent SBP
on multivariate analysis in this study, but this finding is
explained by the fact that 71.8% of our study cohort
included patients with Hepatitis C related cirrhosis.
Overall, this is the first study from Pakistan which would
address the factors that are mainly responsible for the
recurrence of SBP, but there remains a constraint of it
being a single center study. There should be similar
studies from other parts of the country and from South
East Asia so that we are able to learn more related to
this issue or similar factors which are largely responsible
for this problem and, therefore, be able to adopt
preventive measures and check repeated admission of
patients.
CONCLUSION
Recurrent SBP was noticed in 34% patients with end
stage liver disease or cirrhosis. Serum bilirubin level of
> 1.0 mg [(OR 7.03; 95%CI=1.55-32), protective factor
of HBV (OR 0.31; 95%CI=0.13-0.70)] and presence of
UTI [(OR=2.24; 95%CI=0.99-5.09)] were significant
factors associated with recurrent SBP.
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